IDM Pharma, Inc. (IDMI)

[bowonwing]

From a market cap perspective: IDM 28.35M shares; simple math @$10= $283.35M market cap, plus figure in whatever cash is left at the time of the sale, which at the end of 2008 was listed as $18.38M (source: Yahoo);
@$5= $141.75M. I still believe the sale price of IDM will be between $5 to $10 a share.

Mepact, after approval, is now for real, at least in the EU, and in the pipe is IDM-2101. If these drugs can do one half of what some people have said they believe they will do for cancer patients, IDM should be sold for $1.4175B! or $50 a share. (Alright, so I said it).

I do not think P.A. will take anything less than $5 a share or $141.75M market cap. We are in the mist of the greatest financial deleveraging since the end of WWII, but I do not think P.A. will let some shark "steal" IDM for a song. My guesstimate, $8.50 a share, or $240.98 market cap, plus the $10M or so of cash that is left. JMHO